Stockholders approve 15.9M share increase to 2018 Equity Incentive Plan

Organogenesis Holdings Inc.

All 11 director nominees elected; votes ranged from 41.5M to 68.4M for, with broker non-votes of 39.3M.
Advisory vote on executive compensation passed with 63.8M for, 5.9M against.
Amendment to 2018 Equity Incentive Plan adding 15,900,000 shares approved (52.0M for, 17.7M against).
Ratification of RSM US LLP as independent auditor for FY2024 passed (106.4M for, 2.6M against).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.